Genertec Universal Medical Group Company Limited (5UM) — Cash Flow Quality Index
Genertec Universal Medical Group Company Limited (5UM) has a Cash Flow Quality Index of -2.94x as of June 2023. Operating cash flow of €-1.67 Billion is below net income of €567.98 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 5UM operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Genertec Universal Medical Group Company Limited Cash Flow Quality Index (2016–2025)
Historical Cash Flow Quality Index for Genertec Universal Medical Group Company Limited across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash flow conversion of Genertec Universal Medical Group Company.
Annual Cash Flow Quality Index for Genertec Universal Medical Group Company Limited (2016–2025)
Year-by-year earnings quality comparison for Genertec Universal Medical Group Company Limited.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.61x | €5.78 Billion | €2.21 Billion | ▲ +366.7% |
| 2024 | 0.56x | €1.14 Billion | €2.03 Billion | ▼ -77.3% |
| 2023 | 2.47x | €4.99 Billion | €2.02 Billion | ▲ +127.0% |
| 2022 | 1.09x | €2.06 Billion | €1.89 Billion | ▲ +242.6% |
| 2021 | -0.76x | €-1.40 Billion | €1.84 Billion | ▼ -29.4% |
| 2020 | -0.59x | €-971.72 Million | €1.65 Billion | ▲ +48.6% |
| 2019 | -1.15x | €-1.82 Billion | €1.59 Billion | ▲ +72.9% |
| 2018 | -4.24x | €-5.73 Billion | €1.35 Billion | ▲ +4.1% |
| 2017 | -4.42x | €-5.07 Billion | €1.15 Billion | ▼ -61.7% |
| 2016 | -2.73x | €-2.38 Billion | €872.31 Million | — |